Business Development Director
Vericel Corporation
Summary
The Business Development Director will play a key role in identifying, evaluating, and executing business development opportunities that support Vericel's long-term growth strategy and expand its portfolio of innovative therapies. Reporting to the Senior Vice President, Business Development & Strategy, this individual will be a highly analytical, commercially minded and action-oriented deal professional who can move seamlessly from opportunity identification and financial analysis through diligence, valuation, negotiation and transaction execution.
Job description
Key Responsibilities
Opportunity Identification & Pipeline Development
- Proactively identify and source acquisition (US, global, and regional), licensing, partnership, and other strategic opportunities aligned with Vericel's growth strategy.
- Develop and maintain an active pipeline of potential opportunities across relevant therapeutic areas, technologies, and markets.
- Build relationships with biotechnology and medical technology companies, investment bankers, venture investors, business development professionals and other industry participants to expand Vericel's network and proprietary deal flow.
- Attend industry conferences, partnering meetings, and other external events to identify opportunities and develop relationships.
- Monitor industry activity, transactions, emerging technologies, and competitive developments to identify opportunities relevant to Vericel.
Opportunity Assessment & Financial Analysis
- Lead initial assessment of potential business development opportunities, including strategic fit, market opportunity, competitive positioning, development risk and financial attractiveness.
- Build and maintain detailed valuation and financial models, including revenue forecasts, probability-adjusted scenarios, discounted cash flow analyses, transaction structures and return analyses.
- Develop market, competitive, and company analyses to support investment decisions.
- Evaluate transaction economics across acquisitions, licenses, partnerships and other deal structures.
- Conduct scenario and sensitivity analyses to identify key assumptions, risks, and value drivers.
- Translate complex analyses into concise recommendations for senior management.
Due Diligence & Deal Execution
- Lead and coordinate cross-functional diligence processes for potential transactions, partnering with Medical, Commercial, R&D, Regulatory, Operations, Finance, Legal, and other functions.
- Ability to secure cross-functional alignment on results of due diligence and formulation of next steps.
- Develop diligence plans, establish workstreams and timelines, track findings and ensure key risks and opportunities are surfaced for decision-making.
- Maintain a clear, integrated view of scientific, clinical, regulatory, commercial, operational, and financial diligence findings.
- Identify potential deal issues early and drive resolution with internal and external stakeholders.
- Support development and negotiation of term sheets, letters of intent, licensing agreements, acquisition agreements, and other transaction documents in partnership with Legal and external advisors.
- Develop financial and strategic analyses supporting transaction structure and negotiation strategy.
- Coordinate external advisors, consultants, investment banks, and other parties involved in transaction execution.
- Drive transactions forward with urgency, discipline, and attention to detail from initial evaluation through signing and closing.
- Lead cross-functional integration efforts post-transaction.
Executive Decision Support
- Prepare investment recommendations, transaction analyses, and decision materials for the SVP, CEO, executive leadership, and Board, as appropriate.
- Clearly articulate the strategic rationale, economics, risks, alternatives, and key decision points associated with potential transactions.
- Develop concise executive presentations that translate complex opportunities into actionable business decisions.
- Provide thoughtful, independent perspectives and challenge assumptions when appropriate.
- Maintain current views on active opportunities and provide clear recommendations regarding which opportunities Vericel should pursue, continue evaluating or discontinue.
Market & Strategic Intelligence
- Maintain deep knowledge of relevant therapeutic markets, competitors, technologies, clinical programs, and transaction activity.
- Track precedent transactions, valuation trends, and evolving deal structures across biotechnology, pharmaceutical, regenerative medicine, and medical technology markets.
- Develop perspectives on emerging areas that may represent future growth opportunities for Vericel.
Requirements
- Bachelor's degree in Finance, Economics, Business, Life Sciences, Engineering, or related discipline required
- MBA or other advanced degree preferred
- 7+ years of relevant professional experience
- Investment banking experience strongly preferred, particularly within healthcare, biotechnology, pharmaceuticals, or medical technology
- Demonstrated transaction experience involving M&A, licensing, partnerships, investments, or other strategic transactions
- Strong financial modeling and valuation capabilities, including DCF, comparable-company, precedent-transaction, and scenario analyses
- Demonstrated ability to evaluate businesses and opportunities from strategic, financial, and commercial perspectives
- Experience managing complex diligence processes involving multiple functional stakeholders
- Strong understanding of financial statements, transaction structures and deal economics
- Ability to quickly understand scientific, clinical, and technical information and translate it into business and investment implications
- Excellent written, verbal, and presentation skills with demonstrated ability to communicate effectively with senior executives
- Advanced PowerPoint and Excel capabilities
- Experience transitioning from healthcare investment banking into an operating biotechnology, pharmaceutical, or medical technology company
- Experience evaluating or executing transactions involving commercial-stage or late-stage healthcare assets
- Experience in cell therapy, regenerative medicine, orthopedics, sports medicine, burn care, biologics, or adjacent therapeutic areas
- Experience with licensing and asset-level transactions in addition to traditional M&A
- Established network across biotechnology, pharmaceutical, medical technology, banking, venture capital, and business development communities
Benefits
- Bonus
- Incentive Pay
- Equity
- Medical, Dental & Vision
Company overview
Vericel Corporation is a leading biotechnology company specializing in advanced cell therapies for sports medicine and severe burn care markets. Founded in 1989 and headquartered in Cambridge, Massachusetts, the company develops and commercializes patient-specific expanded cellular therapies that repair injuries and restore lives. Vericel markets two FDA-approved autologous cell therapy products in the United States: Carticel for cartilage defects in the knee and Epicel for permanent skin replacement in severe burn patients. The company also holds exclusive North American commercial rights to NexoBrid, a biological orphan product for eschar removal in thermal burns. Vericel's innovative approach combines biology with medical technologies to create highly differentiated cell therapies and specialty biologics. With a focus on regenerative medicine, the company is advancing treatments for cartilage repair, burn care, and other severe conditions through rigorous scientific methods and clinical research.